ATLAS detects rare Higgs boson decays occurring once in every 5,000 events
However, recent breakthroughs by the ATLAS collaboration at CERN have begun to unlock some of its most mysterious behaviors, including two incredibly rare decays.
These decays, where the Higgs boson transforms into a pair of muons (H→μμ) or a Z boson and a photon (H→Zγ), are so scarce that they only occur in one out of every few thousand Higgs decays.
The research could pave the way for discovering unknown particles and help us uncover the various mysteries associated with the God particle.
Uncovering these rare decays wasn't easy. The ATLAS collaboration, a group of scientists working at CERN's Large Hadron Collider (LHC), spent years gathering data from their experiments. The first challenge they faced was the rarity of these events.
The Higgs boson's decay into muons happens in only about one in every 5000 Higgs decays. So, the team had to search for a tiny signal amidst a vast amount of background noise caused by other particle interactions.
To make the search more efficient, scientists combined data from LHC Runs 2 and 3, which gave them a more complete picture. With this enhanced data, ATLAS researchers used advanced techniques to filter out the background noise and focus on the events that showed signs of the rare Higgs decays.
In the case of H→μμ, they looked for a small bump in the mass of the muon pair, right at 125 GeV, the known mass of the Higgs. Meanwhile, the H→Zγ decay presented an even tougher challenge.
The Z boson that is produced in this decay only decays into electron or muon pairs about six percent of the time, and photons are notoriously difficult to distinguish from jets of particles created in other processes.
Here, ATLAS developed new analysis methods to improve the sensitivity of their search. By categorizing events based on how the Higgs was produced and refining their selection criteria, the team was able to see a clearer signal.
Their hard work paid off: For the H→μμ decay, they achieved a 3.4 standard deviation significance, which means the result is highly unlikely (one in 3000) to be a statistical fluke.
This was a significant improvement over earlier results, which had only shown a hint of the decay at the two-standard-deviation level. For the H→Zγ decay, the team found an excess signal with 2.5 standard deviations, which was also an important step forward compared to previous results.
These breakthroughs could have wide-scale implications. By uncovering the rare decays, the ATLAS collaboration is opening the door to exploring physics beyond the Standard Model. Unknown particles contributing to the H→Zγ decay could be an indication of physics that is still unexplored.
https://youtu.be/vMdSljE8NpM
However, there are still challenges. While these results are groundbreaking, they are not yet definitive. Looking ahead, ATLAS researchers plan to dig deeper into rare Higgs decays with even more data from future runs of the LHC.
The team hopes that future data will not only confirm these findings but also reveal more details about how the Higgs interacts with other particles, especially those that haven't been studied as much, like the second-generation fermions.
You can read about the two decays in more detail here and here.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
19 minutes ago
- Yahoo
New test could revolutionise aftercare for thousands of breast cancer patients
Scientists have developed a new test for certain breast cancer patients which can predict whether or not their cancer is likely to return just two weeks after they start treatment. Experts said thousands of breast cancer patients could be spared unnecessary treatment as a result. The new test has been devised to detect the likelihood of cancer reoccurring in patients with a type of breast cancer known as oestrogen receptor positive, human epidermal growth factor receptor 2 positive – which accounts for around 200,000 cases of cancer each year around the globe. Writing in the journal eBioMedicine, experts said the test means that some patients will be able to 'de-escalate' their treatment while it could also help identify those who need 'more intensive therapeutic strategies'. The test, which was developed by scientists at The Institute for Cancer Research, London, correctly identifies the 6% of patients at highest risk of relapse. Researchers analysed tumour samples from 213 patients. They found that two weeks of hormone therapy changes the characteristics of some tumours, causing them to shift their subtype. The patients with the highest risk of cancer returning had a type of tumour called Luminal B that did not change after this short-term hormone therapy. Experts said these patients will require more intensive treatment. This is your breast check reminder! Learn the signs and symptoms of breast — Breast Cancer Now (@BreastCancerNow) May 6, 2025 They said the findings highlight the benefit of two weeks of hormone therapy before surgery to help guide doctors' decision making. Corresponding author of the study, Dr Maggie Cheang, from The Institute of Cancer Research, London, said: 'To deliver truly personalised care, we need to refine how we classify breast cancer, so that each patient receives the treatment most likely to benefit them. 'While current classification relies on hormone receptor and HER2 status, we know that patients within these groups can respond very differently to the same therapy. 'Our earlier research identified distinct molecular subtypes within HER2-positive, oestrogen receptor-positive breast cancer. In this new study, we've shown that these subtypes can shift after just two weeks of hormone therapy. 'This insight helps us identify which patients are likely to respond well and which may show early signs of treatment resistance, offering the opportunity to tailor treatment strategies sooner. 'Ultimately, our findings move us closer to more precise, patient-centred care for this overlooked breast cancer subtype.' Professor Kristian Helin, chief executive of The Institute of Cancer Research, London, added: 'By decoding the underlying biology of tumours, we can tailor treatments to individual patients.' Dr Simon Vincent, chief scientific officer at Breast Cancer Now, which part-funded the study, said: 'These findings add to the growing evidence that genomic testing can play a powerful role in helping to predict the risk of a woman's breast cancer coming back, particularly in people with ER-positive, HER2-positive breast cancer. 'There's potential for women to benefit hugely from this research in the future, with it ensuring they avoid undergoing unnecessary treatment and leading to more personalised treatment plans, so that women receive the most effective therapy for their specific type of breast cancer.'
Yahoo
3 hours ago
- Yahoo
Unique 1.5m year-old ice to be melted to unlock mystery
An ice core that may be older than 1.5 million years has arrived in the UK where scientists will melt it to unlock vital information about Earth's climate. The glassy cylinder is the planet's oldest ice and was drilled from deep inside the Antarctic ice sheet. Frozen inside is thousands of years of new information that scientists say could "revolutionise" what we know about climate change. BBC News went inside the -23C freezer room at the British Antarctic Survey in Cambridge to see the precious boxes of ice. "This is a completely unknown period of our Earth's history," says Dr Liz Thomas, head of ice core research at the British Antarctic Survey. Red warning lights flash above the door, and inside there is an emergency escape hatch into a tunnel in case something went wrong. The rules say we could only go inside for 15 minutes at a time, wearing padded overalls, boots, hats and gloves. Our camera's electronic shutter froze shut and our hair started to crackle as it turned icy. On a worktop next to stacked boxes of ice, Dr Thomas points out the oldest cores that could be 1.5 million years old. They shine and are so clear we can see our hands through them. For seven weeks, the team will slowly melt the hard-won ice, releasing ancient dust, volcanic ash, and even tiny marine algae called diatoms that were locked inside when water turned to ice. These materials can tell scientists about wind patterns, temperature, and sea levels more than a million years ago. Tubes will feed the liquid into machines in a lab next door that is one of the only places in the world that can do this science. It was a huge multinational effort to extract the ice cores in Antarctica, at a cost of millions. The ice was chopped into 1m blocks and transported by boat and then in a cold van to Cambridge. Engineer James Veal helped to extract the ice close to the Concordia base in eastern Antarctica. "To hold that in my carefully gloved hands and be very careful not to drop the sections - it was an amazing feeling," he says. Two institutions in Germany and Switzerland also have received cross-sections of the 2.8km core. The teams could find evidence of a period of time more than 800,000 years ago when carbon dioxide concentrations may have been naturally as high or even higher than they are now, according to Dr Thomas. This could help them understand what will happen in our future as our planet responds to warming gases trapped in our atmosphere. "Our climate system has been through so many different changes that we really need to be able to go back in time to understand these different processes and different tipping points," she says. The difference between today and previous eras with high greenhouse gases is that now humans have caused the rapid rise in warming gases in the last 150 years. That is taking us into unchartered territory, but the scientists hope that the record of our planet's environmental history locked in the ice could give us some guidance. The team will identify chemical isotopes in the liquid that could tell us the wind patterns, temperatures, and rainfall for a period of time between 800,000 and up to 1.5 million years ago or possibly more. They will use an instrument called an inductively couple plasma mass spectrometer (ICPMS) to measure over 20 elements and trace metals. That includes rare earth elements, sea salts and marine elements, as well as indicators of past volcanic eruptions. The work will help scientists understand a mysterious change called the Mid-Pleistocene Transition 800,000 to 1.2 million years ago when the planet's glacial cycles suddenly changed. The transition from warmer eras to cold glacial eras, when ice covered a lot more of Earth, had been every 41,000 years but it suddenly switched to 100,000 years. The cause of this shift is one of the "most exciting unsolved questions" in climate science, according to Dr Thomas. The cores may have evidence of a time when sea levels were much higher than they are now and when the vast Antarctic ice sheets were smaller. The presence of dust in the ice will help them understand how the ice sheets shrunk and contributed to sea level rise - something that is a major concern this century. Million year-old bubbles could solve ice age mystery Solve the daily Crossword
Yahoo
7 hours ago
- Yahoo
Testosterone gel: what happens if it rubs off on other people
A case that first appeared in a medical journal several years ago has recently resurfaced in the media, highlighting an unexpected risk of hormone therapies: a baby girl in Sweden developed unusually large genitals after lying on her father's bare chest, accidentally exposed to his testosterone gel. The incident is a reminder that hormone treatments, while safe when used correctly, can pose risks to others if proper precautions aren't followed. Testosterone is a powerful sex hormone that plays a crucial role in male development. In the early months of life, babies undergo rapid development, making their bodies, and hormones, extremely sensitive. Even small amounts of testosterone absorbed through the skin can affect a baby's development, particularly with repeated exposure. Get your news from actual experts, straight to your inbox. Sign up to our daily newsletter to receive all The Conversation UK's latest coverage of news and research, from politics and business to the arts and sciences. During 'mini-puberty' – a short surge in hormone levels occurring a few months after birth – boys experience rising testosterone levels that help complete reproductive system development and prime it for adulthood. This process also influences brain development. In girls, oestrogen rises slightly during this period, but testosterone remains very low. When a girl is exposed to external testosterone, such as from hormone gel, it can cause unexpected changes, including enlarged clitoris or fusion of the labia. This is precisely what occurred in the Swedish case. Testosterone gels are commonly prescribed to treat men with low testosterone deficiency. The gel is typically applied once daily to clean, dry skin on the shoulders, upper arms or stomach. These alcohol-based gels help the hormone absorb into the skin. While the gel dries within minutes, residue can remain on the skin for an hour or two after application. If someone touches the treated area too soon, or rests directly on it, they can inadvertently absorb some of the hormone. This risk is particularly significant for babies and children, whose thinner, more absorbent skin and developing bodies make them more vulnerable. Testosterone gels are also increasingly used off-label in women to treat menopause symptoms (such as low libido, low mood and fatigue) and at around one-tenth of the dose given to men. This lower dose is achieved by applying a smaller amount of the same male product — this time to the lower abdomen, buttocks or outer thighs. This means there's much less hormone overall, but incidental exposure from women is also possible, for example, when holding a child soon after application. Some perspective While stories like this understandably cause concern, it's crucial to understand the actual risk level. In the UK, around 50,000 to 100,000 people are prescribed testosterone on the NHS, with gel formulations popular due to their ease of application. If accidental exposure were common, we would see far more cases than the small number reported in medical journals. The instructions accompanying these gels are clear: apply only to specified areas, wash hands immediately, cover the skin once dry and avoid close skin contact for several hours. When these guidelines are followed, transfer is very unlikely. In the case of the Swedish child, when the father stopped resting the baby on his bare chest, the genital changes reversed over time. This pattern holds true for other reported cases – if exposure stops early, many effects can fade naturally. However, in more severe or prolonged cases, children may need medical treatment. This could include hormonal tests, continued monitoring, anti-hormone treatment, or even surgery if physical changes don't resolve. Early intervention is key, making it essential to consult a doctor if there's any concern. For those with babies, young children, or pregnant partners at home, the solution is straightforward planning. Apply the gel when you won't be in direct contact immediately afterwards, or consider alternative application methods such as injections, skin patches, or tablets (available in the US), which carry lower risks of unintentional exposure to others. This case serves as a valuable reminder that testosterone therapy, like all medications, comes with responsibilities. When used properly, it's an effective treatment for men with diagnosed testosterone deficiency, improving sexual function and mood, with evidence suggesting it can also support muscle mass, bone health, and metabolism. There is no need to fear these treatments, but if you are prescribed this medication, use it responsibly and follow the instructions carefully. This article is republished from The Conversation under a Creative Commons license. Read the original article. Daniel Kelly does not work for, consult, own shares in or receive funding from any company or organisation that would benefit from this article, and has disclosed no relevant affiliations beyond their academic appointment.
